Aldosterone and refractory hypertension

Moffat J Nyirenda, Paul L Padfield

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Evidence from clinical trials suggests that refractory hypertension is increasingly common. The underlying mechanisms are largely unknown but recent data have implicated increased aldosterone activity as an important mediator of resistance to routinely used antihypertensive agents.
Original languageEnglish
Pages (from-to)213-8
Number of pages6
JournalCurrent Opinion in Endocrinology, Diabetes and Obesity
Issue number3
Publication statusPublished - 2007


Dive into the research topics of 'Aldosterone and refractory hypertension'. Together they form a unique fingerprint.

Cite this